Argan (AGX) Common Equity (2011 - 2026)

Argan has reported Common Equity for 16 years, with the latest figure at $462.3 million in Q1 2026.

• Quarterly Common Equity rose 31.38% year-over-year to $462.3 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $462.3 million (up 31.38% YoY) and the FY2026 annual result came in at $462.3 million, up 31.38% from the prior year.
• Common Equity rose to $462.3 million in Q1 2026 per AGX's latest filing, from $419.7 million in the prior quarter.
• Over five years, Common Equity peaked at $462.3 million in Q1 2026 and troughed at $271.7 million in Q4 2022.
• A 5-year average of $324.5 million and a median of $302.0 million in 2022 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2026: Common Equity slipped 22.31% in 2022, then surged 31.38% in 2026.
• Over 5 years, Common Equity stood at $271.7 million in 2022, then increased by 4.82% to $284.8 million in 2023, then grew by 15.4% to $328.7 million in 2024, then climbed by 27.69% to $419.7 million in 2025, then advanced by 10.14% to $462.3 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $462.3 million, $419.7 million, and $393.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.